知名生物医学期刊中的性别与性取向报告政策分析
Analysis of Sex and Gender Reporting Policies in Preeminent Biomedical Journals.
作者信息
Bibb Lorin A, Adkins Brian D, Booth Garrett S, Shelton K Maureen, Jacobs Jeremy W
机构信息
Department of Dermatology, University of Connecticut Health, Farmington.
Division of Transfusion Medicine and Hemostasis, Department of Pathology, University of Texas Southwestern, Dallas.
出版信息
JAMA Netw Open. 2022 Aug 1;5(8):e2230277. doi: 10.1001/jamanetworkopen.2022.30277.
Abstract
This cross-sectional study evaluates prominent journals’ sex and gender reporting guidelines.
摘要
这项横断面研究评估了著名期刊的性别报告指南。
相似文献
1
Analysis of Sex and Gender Reporting Policies in Preeminent Biomedical Journals.知名生物医学期刊中的性别与性取向报告政策分析
JAMA Netw Open. 2022 Aug 1;5(8):e2230277. doi: 10.1001/jamanetworkopen.2022.30277.
2
Editorial: Improving How Orthopaedic Journals Report Research Outcomes Based on Sex and Gender.社论：改进骨科期刊报告基于性别和性别的研究结果的方式。
Clin Orthop Relat Res. 2024 Jul 1;482(7):1101-1103. doi: 10.1097/CORR.0000000000003140. Epub 2024 Jun 10.
3
Retraction policies of top scientific journals ranked by impact factor.按影响因子排名的顶级科学期刊的撤稿政策。
J Med Libr Assoc. 2015 Jul;103(3):136-9. doi: 10.3163/1536-5050.103.3.006.
4
The Role of Journals in Reporting Sex and Gender-Based Outcomes: Should We Adopt Guidelines, and What Else Can We Do to Improve Reporting?期刊在报告性别相关结局中的作用：我们是否应该采用指南，以及还有什么其他方法可以改善报告？
J Bone Joint Surg Am. 2024 Sep 4;106(17):1610-1614. doi: 10.2106/JBJS.24.00035. Epub 2024 Jul 29.
5
Dual-use review policies of biomedical research journals.生物医学研究期刊的两用审查政策。
Biosecur Bioterror. 2011 Mar;9(1):49-54. doi: 10.1089/bsp.2010.0067.
6
[Editorial and scientific excellence of biomedical journals: Is the impact factor everything?].[生物医学期刊的编辑与科学卓越性：影响因子就是一切吗？]
Arch Cardiol Mex. 2015 Oct-Dec;85(4):265-9. doi: 10.1016/j.acmx.2015.10.001. Epub 2015 Oct 27.
7
Conflict of interest reporting in biomedical journals published in China.中国生物医学期刊中的利益冲突报告。
Account Res. 2017;24(8):451-457. doi: 10.1080/08989621.2017.1392246. Epub 2017 Oct 30.
8
Misconduct policies in high-impact biomedical journals.高影响力生物医学期刊的不当行为政策。
PLoS One. 2012;7(12):e51928. doi: 10.1371/journal.pone.0051928. Epub 2012 Dec 19.
9
Medical journals and medical reporting.医学期刊与医学报道。
N Engl J Med. 2000 Jun 1;342(22):1668-71. doi: 10.1056/NEJM200006013422212.
10
Good publication practice in physiology 2017: Current Revisions of the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals.《2017年生理学领域良好发表规范：医学期刊中学术成果的撰写、报告、编辑及发表建议的当前修订版》
Acta Physiol (Oxf). 2017 Dec;221(4):283-284. doi: 10.1111/apha.12984. Epub 2017 Nov 8.
引用本文的文献
1
Evaluating Covid-19 publications for sex and gender-specific health content: A bibliometric analysis.评估关于新冠病毒病（Covid-19）的出版物中的性别特异性健康内容：一项文献计量分析。
PLoS One. 2025 Feb 19;20(2):e0316812. doi: 10.1371/journal.pone.0316812. eCollection 2025.
2
Sex and gender-based analysis and diversity metric reporting in acute care trials published in high-impact journals: a systematic review.高影响力期刊发表的急性护理试验中的基于性别的分析和多样性指标报告：系统评价。
BMJ Open. 2024 May 7;14(5):e081118. doi: 10.1136/bmjopen-2023-081118.
3
Gender versus sex: recognizing and adhering to established guidelines for diversity, equity, and inclusion research.性别与性：认识并遵循关于多样性、公平性和包容性研究的既定指南
Acad Pathol. 2024 Feb 29;11(1):100104. doi: 10.1016/j.acpath.2023.100104. eCollection 2024 Jan-Mar.
4
Sex or Gender Reporting in Ophthalmology Clinical Trials Among US Food and Drug Administration Approvals, 1995 to 2022.《1995 年至 2022 年美国食品和药物管理局批准的眼科临床试验中的性别报告》。
JAMA Ophthalmol. 2024 Feb 1;142(2):123-130. doi: 10.1001/jamaophthalmol.2023.6088.
本文引用的文献
1
Sex and gender reporting in high impact haematology journals.高影响力血液学杂志中的性别与性别的报道
Lancet Haematol. 2022 Jun;9(6):e392-e394. doi: 10.1016/S2352-3026(22)00114-4. Epub 2022 Apr 28.
2
Reporting Sex, Gender, or Both in Clinical Research?在临床研究中报告性别、社会性别还是两者都报告？
JAMA. 2016 Nov 8;316(18):1863-1864. doi: 10.1001/jama.2016.16405.
Zotero 插件